EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Medicaid Expansion and Overall Survival of Lower Gastrointestinal Cancer Patients After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy

Kirithiga Ramalingam, Liang Ji, Michael P O'Leary, Sharon S Lum, David Caba Molina

Annals of Surgical Oncology · 2025

DOI: 10.1245/s10434-024-16446-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Surgical Oncology, 2025. Verfasst von Kirithiga Ramalingam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of California San Francisco, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Medicaid, Cytoreduction Surgical Procedures, Hyperthermic Intraperitoneal Chemotherapy, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Loma Linda University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In the United States, often only tertiary centers offer cytoreductive surgery and heated intraperitoneal chemotherapy (CRS+HIPEC) for peritoneal metastases in advanced lower gastrointestinal malignancies. Growing evidence shows that Medicaid expansion under the Affordable Care Act (ACA) of 2010 enhanced healthcare access and outcomes.

Objective

We sought to determine whether Medicaid expansion was associated with decreased all-cause mortality of lower gastrointestinal cancer patients following CRS+HIPEC.

Methods

We analyzed data from the National Cancer Database (2010–2019) on lower gastrointestinal cancer patients who underwent CRS+HIPEC. Medicaid expansion, introduced under the ACA in 2010, extends health insurance to low-income adults. We categorized states by expansion timing: early (2010–2013), immediate (January 2014), late (after January 2014), or no expansion to assess the impact of Medicaid expansion on mortality using a multivariable Cox regression model.

Results

Of the 1001 study patients, 671 (67%) were diagnosed in Medicaid expansion states. Grade and Medicaid expansion status were the only factors independently associated with overall survival on multivariable analysis. On average, patients in Medicaid expansion states experienced a 4% increase in annual survival compared with those in non-expansion states who had a 1% decrease in annual survival over the study period.

Conclusions

Patients from states that had an early expansion of Medicaid and patients with lower-grade tumors had significantly better overall survival. Our study findings suggest that improved access to healthcare through Medicaid expansion was associated with increased survival rates of lower gastrointestinal cancer patients who undergo CRS+HIPEC for the treatment of peritoneal metastases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MedicaidCytoreduction Surgical ProceduresHyperthermic Intraperitoneal ChemotherapyGastrointestinal NeoplasmsPeritoneal NeoplasmsPatient Protection and Affordable Care ActHumansUnited StatesFemaleMaleSurvival RateMiddle AgedFollow-Up StudiesPrognosisCombined Modality TherapyAgedHealth Services AccessibilityRetrospective StudiesAntineoplastic Combined Chemotherapy Protocols

Autor:innen und Institutionen

  • Department of Surgery, University of California San Francisco, San Francisco, CA, USA.
  • School of Public Health, Loma Linda University, Loma Linda, CA, USA.
  • Department of Surgical Oncology, University of California Irvine, Irvine, CA, USA.
  • Department of Surgery, Loma Linda University, Loma Linda, CA, USA.
  • Loma Linda University, Loma Linda, CA, USA. davidcm4@yahoo.com.
  • Riverside University Health System Medical Center, Moreno Valley, CA, USA. davidcm4@yahoo.com.

Förderung

  • Loma Linda University

Zitieren

APA

Ramalingam, K., Ji, L., O'Leary, M. P., Lum, S. S., & Caba Molina, D. (2025). Medicaid Expansion and Overall Survival of Lower Gastrointestinal Cancer Patients After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-024-16446-8

Vancouver

Ramalingam K, Ji L, O'Leary MP, Lum SS, Caba Molina D. Medicaid Expansion and Overall Survival of Lower Gastrointestinal Cancer Patients After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy. Annals of Surgical Oncology. 2025. doi:10.1245/s10434-024-16446-8

BibTeX
@article{Ramalingam2025,
  author = {Ramalingam, Kirithiga and Ji, Liang and O'Leary, Michael P and Lum, Sharon S and Caba Molina, David},
  title = {Medicaid Expansion and Overall Survival of Lower Gastrointestinal Cancer Patients After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy},
  journal = {Annals of Surgical Oncology},
  year = {2025},
  doi = {10.1245/s10434-024-16446-8}
}
Kostenlos starten →